Article

Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN.

Institut Pasteur, Unité de Résonance Magnétique Nucléaire des Biomolécules, Département de Biologie Structurale et Chimie, F-75015 Paris, France.
Science Signaling (Impact Factor: 7.65). 08/2012; 5(237):ra58. DOI: 10.1126/scisignal.2002941
Source: PubMed

ABSTRACT PTEN (phosphatase and tensin homolog deleted on chromosome 10) and MAST2 (microtubule-associated serine and threonine kinase 2) interact with each other through the PDZ domain of MAST2 (MAST2-PDZ) and the carboxyl-terminal (C-terminal) PDZ domain-binding site (PDZ-BS) of PTEN. These two proteins function as negative regulators of cell survival pathways, and silencing of either one promotes neuronal survival. In human neuroblastoma cells infected with rabies virus (RABV), the C-terminal PDZ domain of the viral glycoprotein (G protein) can target MAST2-PDZ, and RABV infection triggers neuronal survival in a PDZ-BS-dependent fashion. These findings suggest that the PTEN-MAST2 complex inhibits neuronal survival and that viral G protein disrupts this complex through competition with PTEN for binding to MAST2-PDZ. We showed that the C-terminal sequences of PTEN and the viral G protein bound to MAST2-PDZ with similar affinities. Nuclear magnetic resonance structures of these complexes exhibited similar large interaction surfaces, providing a structural basis for their binding specificities. Additionally, the viral G protein promoted the nuclear exclusion of PTEN in infected neuroblastoma cells in a PDZ-BS-dependent manner without altering total PTEN abundance. These findings suggest that formation of the PTEN-MAST2 complex is specifically affected by the viral G protein and emphasize how disruption of a critical protein-protein interaction regulates intracellular PTEN trafficking. In turn, the data show how the viral protein might be used to decipher the underlying molecular mechanisms and to clarify how the subcellular localization of PTEN regulates neuronal survival.

Download full-text

Full-text

Available from: Zakir Khan, Jul 07, 2015
0 Followers
 · 
237 Views
  • Source
    • "Other modes of PTEN recruitment to the plasma membrane involve interactions with proteins such as MAGI-2, MAGI-3, SAST (also known as MAST1), MAST3, NHEFR1 and NHEFR2 through its PDZ domain at the C-terminal end (explained in the later sections) [84] [85] [86] [87]. In a recent finding, it was found that human neuroblastoma cells infected with rabies virus (RABV), the viral glycoprotein (G protein) interfered with the PTEN-MAST2 interaction due to a high affinity for the MAST2 protein as a result of which PTEN is re-localized to the cytoplasm [88]. With the advancement in microscopic techniques, it has now been possible to visualize the localization and even the retention of PTEN in specific cellular locations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: PTEN (Phosphatase and Tensin Homolog deleted on Chromosome TEN), the tumor suppressor is the regulator-in-chief of a variety of cellular processes that include cell proliferation, growth, migration and death. Since its identification, numerous reports of PTEN loss or mutation in multiple cancer types has rendered this gene to be one of the most frequently affected tumor suppressors of the post p53 era. With the ever increasing number of processes under PTEN surveillance, the master regulator itself should be under strict control. Although PTEN can be regulated at the genetic and epigenetic levels, post-translational modulations emerge as the focal point of regulation. Here, we will outline the key regulatory aspects of PTEN with an emphasis on the post-translational front. Exciting new evidences will be put forth for the sub-cellular trafficking of PTEN that regulates its functioning with a focus on ubiquitination, phosphorylation and sumoylation. The ability of PTEN to form protein scaffold structures has been overviewed from the aspect of novel regulatory mechanism. The probable contribution of these regulatory mechanisms in suppression or elevation of the tumor suppressive role of PTEN will be discussed. The role of the carboxyl terminus of PTEN in combating its negative regulators will be analyzed as a potential therapeutic approach. Overall, these under-rated, emerging modes of PTEN modulations significantly re-focus the established notion of PTEN regulation and might be targeted in unraveling novel cancer therapeutics.
    PTEN: Structure, Mechanisms-of-Action, Role in Cell Signaling and Regulation, Protein Science and Engineering; Protein Biochemistry, Synthesis, Structure and Cellular Functions edited by Ke Xu, 01/2013: chapter 2: pages 51-78; Nova Science Publishers., ISBN: 978-1-62808-049-0
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: PTEN phosphatase is a tumor suppressor controlling notably cell growth, proliferation and survival. The multi-site phosphorylation of the PTEN C-terminal tail regulates PTEN activity and intracellular trafficking. The dynamical nature of such regulatory events represents a crucial dimension for timing cellular decisions. Here we show that NMR spectroscopy allows reporting on the order and kinetics of clustered multi-site phosphorylation events. We first unambiguously identify in vitro seven bona fide sites modified by CK2 and GSK3β kinases and two new sites on PTEN C-terminal tail. Then, monitoring the formation of transient intermediate phosphorylated states, we determine the sequence of these reactions and calculate their apparent rate constants. Finally, we assess the dynamic formation of these phosphorylation events induced by endogenous kinases directly in extracts of human neuroblastoma cells. Taken together, our data indicate that two cascades of events controlled by CK2 and GSK3β occur independently on two clusters of sites (S380-S385 and S361-S370) and that in each cluster the reactions follow an ordered model with a distributive kinetic mechanism. Besides emphasizing the ability of NMR to quantitatively and dynamically follow post-translational modifications, these results bring a temporal dimension on the establishment of PTEN phosphorylation cascades.
    Journal of the American Chemical Society 11/2012; 134(50). DOI:10.1021/ja310214g · 11.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a key regulator of the PI3K/AKT/mTOR pathway, one of the downstream pathways activated by different intracellular mediators which control cell proliferation, differentiation, motility, survival, and metabolism. PTEN along with phosphoinositide 3-kinase makes up a regulatory hub which strictly controls the pool of the second lipid messenger, PtdIns(3,4,5)P3, an activator of the AKT/mTOR pathway. A genomic analysis of breast and other cancers revealed that this regulatory hub is vulnerable to cancer-driving mutations causing a constant activation of AKT signal. It was established that PTEN is a haploinsufficient tumor suppressor gene with one functional allele being insufficient to maintain wild-type function of PTEN which leads to cancer initiation in mice and humans. The observed PTEN dose-dependence of cancer susceptibility strongly indicates that PTEN is under strict control at both translational and post-translational levels. Haploinsufficiency at the PTEN gene is suggested to synergistically interact with post-translation inactivation of PTEN. More than 15 proteins regulate/inhibit PTEN activity through phosphorylation, ubiquitination, and acetylation via more than 15 PTEN regulatory sites. PTEN-modifier proteins form a PTEN regulatory network connecting the PI3K/AKT/mTOR pathway with multiple pathways relevant to cancer development. Heterozygous PTEN mutations were observed to cooperatively interact with genetic aberrations events in this regulatory network providing selective benefits in cancer progression. The PTEN regulatory network has been revealed to be a druggable target in cancer personalized therapy through restoration of PTEN activity in PTEN-deficient cancers.
    PTEN: Structure, Mechanisms-of-Action, Role in Cell Signaling and Regulation, Protein Science and Engineering edited by Ke Xu, 01/2013: chapter Role of Post-translational Regulation of PTEN Activity in Cancer Cell Addiction to Heterozygous PTEN Mutations: pages 173-210; Nova Publishers., ISBN: 978-1-62808-049-0